🇺🇸 FDA
Patent

US 6846829

N-heterocyclic derivatives as NOS inhibitors

expired A61PA61P1/04A61P11/00

Quick answer

US patent 6846829 (N-heterocyclic derivatives as NOS inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/06, A61P13/12